Dr Sean Jason Heller, DC | |
1097 Main St, Hope Valley, RI 02832-1610 | |
(401) 491-9287 | |
(401) 491-9166 |
Full Name | Dr Sean Jason Heller |
---|---|
Gender | Male |
Speciality | Chiropractor |
Location | 1097 Main St, Hope Valley, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245445527 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
111N00000X | Chiropractor | DCP00538 (Rhode Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Sean Jason Heller, DC P.o. Box 1099, Hope Valley, RI 02832 Ph: (401) 491-9287 | Dr Sean Jason Heller, DC 1097 Main St, Hope Valley, RI 02832-1610 Ph: (401) 491-9287 |
News Archive
The leading heart charity, Cardiac Risk in the Young (CRY) is urging all MPs to make a pledge to support a National Strategy for the Prevention of Young Sudden Cardiac Death to help save young lives.
VisionShare, one of the nation's largest and most secure health information exchanges for administrative transactions, today announced plans to expand support for the exchange of clinical transactions on its platform and making connectivity to the Nationwide Health Information Network (NHIN) and state and community-based Health Information Exchanges (HIEs) available to its customers.
New data from the WHO and the Belgian Centre for Research on Epidemiology of Disasters Deaths and released at the U.N. climate conference show the number of people dying in climate-related disasters has decreased, and that economic losses from natural disasters are growing, Reuters AlertNet reports.
A new research study has found that approximately one-third of all individuals with a normal body mass index (BMI) had cardio-metabolic risk factors for heart disease, especially those of South Asian and Hispanic descent.
Pfizer Inc. announced today that it is entering into a partnership with Laboratorio Teuto Brasileiro S.A., a leading company in the Brazilian generics industry, to develop and commercialize generic medicines.
› Verified 3 days ago